Diagnosis and Therapy of Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is one of the leading causes of central vision loss in older adults and is becoming an increasingly important health problem in aging populations. This disease involves complex interactions among oxidative stress, chronic inflammation, retinal pigment epithelium dysfunction, changes in Bruch’s membrane, complement system dysregulation, and genetic factors. Diagnostic advances in retinal imaging, particularly optical coherence tomography (OCT), and a better understanding of morphological and molecular biomarkers have expanded clinicians’ ability to recognize disease course, assess progression risk, and evaluate treatment response. From a therapeutic perspective, AMD management includes AREDS2-based nutritional supplementation in selected cases, anti-vascular endothelial growth factor (anti-VEGF) therapy for the neovascular form, and the development of new approaches such as gene therapy and long-term drug delivery systems. This review briefly discusses the diagnostic and therapeutic aspects of AMD to support evidence-based understanding and clinical practice. Early recognition and appropriate management are important for preserving vision and guiding patient care.

Authors

Institutions

Publication Details

Journal
Cermin Dunia Kedokteran
Published
2026-11-19
DOI
https://doi.org/10.55175/rxrdxc67
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnosis and Therapy of Age-Related Macular Degeneration

Reza Aditya Digambiro, Julian Chendrasari, Florinda Ilona, Husnun Amalia
Cermin Dunia Kedokteran
Retinal Diseases and Treatments
article

Diagnosis and Therapy of Age-Related Macular Degeneration

Reza Aditya Digambiro, Julian Chendrasari, Florinda Ilona, Husnun Amalia
article en

Abstract

Age-related macular degeneration (AMD) is one of the leading causes of central vision loss in older adults and is becoming an increasingly important health problem in aging populations. This disease involves complex interactions among oxidative stress, chronic inflammation, retinal pigment epithelium dysfunction, changes in Bruch’s membrane, complement system dysregulation, and genetic factors. Diagnostic advances in retinal imaging, particularly optical coherence tomography (OCT), and a better understanding of morphological and molecular biomarkers have expanded clinicians’ ability to recognize disease course, assess progression risk, and evaluate treatment response. From a therapeutic perspective, AMD management includes AREDS2-based nutritional supplementation in selected cases, anti-vascular endothelial growth factor (anti-VEGF) therapy for the neovascular form, and the development of new approaches such as gene therapy and long-term drug delivery systems. This review briefly discusses the diagnostic and therapeutic aspects of AMD to support evidence-based understanding and clinical practice. Early recognition and appropriate management are important for preserving vision and guiding patient care.

Cermin Dunia KedokteranVol. 53(11)
Universitas Trisakti (ID)
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon